新冠疫情视角下生物技术风险化解与法律规制

生物技术风险应对必须走到科技的前面去,在风险预防的基础上审慎推动新冠疫情防治生物技术的发展创新;对生物安全威胁的防控更应走到法律的内部去,在法律规范下妥善处置新冠疫情中的生物技术风险.重塑发展生物技术的原则和态度,防范和化解生物技术应用产生的阴霾,创设适宜的生物技术生长的法治空间,实现在法律规制下的生物技术与人类社会的协调向善发展.2020年10月17日《中华人民共和国生物安全法》颁布,完善了生物技术领域法律规范体系,为生物技术健康发展提供导向.随着生物技术在国家发展体系中的地位日益突出、作用日益重要,探索规范生物技术之良法以求生命科学领域之善治,以求在生物技术发展进程中确立和保障社会公益,是生物科技时代的重大法治命题.

Legal Prevention of Biotechnology Risks from the Perspective of COVID-19 Pandemic

Absract:Biotchnology risk response must be considered,before science and technology cautiously promotes the de-velopment and innovation of biotechnology for COVID-19 prevention and control,on the basis of risk prevention.The prevention and control of biosecurity threats should proceed within the law and properly handle the biotechnol-ogy risks in COVID-19 research under legal norms.The goal is to reshape the principles and attitudes for the de-velopment of biotechnology,to prevent and dissolve any ambiguity caused by the application of biotechnology,to create a suitable space for the growth of biotechnology under the rule of law,and to realize the harmonious develop-ment of biotechnology and human society under the regulation of law.The Biosecurity Law of the People's Republic of China was promulgated on October 17,2020,improving the legal and normative system in the field of biotechnol-ogy and providing guidance for the healthy development of biotechnology.With the increasingly prominent position and the important role of biotechnology in national development systems,it is a critical legal proposition in the era of biotechnology to establish fair laws and regulations of biotechnology to achieve good governance in the field of life science,thereby establishing and protecting public welfare in the development process of biotechnology.